US3865118A - Transvenous coaxial catheter - Google Patents
Transvenous coaxial catheter Download PDFInfo
- Publication number
- US3865118A US3865118A US428966A US42896673A US3865118A US 3865118 A US3865118 A US 3865118A US 428966 A US428966 A US 428966A US 42896673 A US42896673 A US 42896673A US 3865118 A US3865118 A US 3865118A
- Authority
- US
- United States
- Prior art keywords
- electrode
- ventricle
- atrial
- catheter
- stimulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001746 atrial effect Effects 0.000 claims abstract description 74
- 230000004936 stimulating effect Effects 0.000 claims abstract description 30
- 210000002837 heart atrium Anatomy 0.000 claims abstract description 28
- 230000000638 stimulation Effects 0.000 claims abstract description 20
- 102100026827 Protein associated with UVRAG as autophagy enhancer Human genes 0.000 abstract description 21
- 101710102978 Protein associated with UVRAG as autophagy enhancer Proteins 0.000 abstract description 21
- 230000002861 ventricular Effects 0.000 abstract description 20
- 210000002216 heart Anatomy 0.000 abstract description 19
- 239000004020 conductor Substances 0.000 abstract description 2
- 238000010276 construction Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- 230000000747 cardiac effect Effects 0.000 description 7
- 230000008901 benefit Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 238000002513 implantation Methods 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000005245 right atrium Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- -1 carbonyl choline Chemical compound 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000003516 pericardium Anatomy 0.000 description 3
- 210000001013 sinoatrial node Anatomy 0.000 description 3
- 208000010271 Heart Block Diseases 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000001174 endocardium Anatomy 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 238000000718 qrs complex Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000002620 vena cava superior Anatomy 0.000 description 2
- 206010001115 Adams-Stokes syndrome Diseases 0.000 description 1
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 206010058039 Cardiac perforation Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000009378 Low Cardiac Output Diseases 0.000 description 1
- 101100119347 Plasmodium falciparum EXP-1 gene Proteins 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 TeflonĀ® Polymers 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004375 bundle of his Anatomy 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 229920006333 epoxy cement Polymers 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000001370 mediastinum Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000036279 refractory period Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
Definitions
- ABSTRACT Pacer catheter for an A-V stimulator comprising a catheter assembly which may be passed through a single channel to the heart which assembly will carry both atrial and ventricular stimulation.
- the catheter provides at least two mutually insulated spatially adjustable electrical conductors, one for stimulating the atrium and an additional one for stimulating the ventricle.
- This invention relates to heart stimulation devices of the catheter type normally used to inter-connect a remotely situated pacer and a source of stimulating energy with the heart of a patient.
- Heart pacers In the electro-medical field today therapeutic heart stimulating devices are well known. Some of these devices are called heart pacers and they provide stimulation to the heart when its natural stimulating system is inoperative or diseased. Artificial stimulation is controlled to cause heartbeat at a substantially normal rate.
- the more conventional pacer provides stimulation only to the ventricle, bypassing the atrium.
- a new type of pacer now coming into use, provides sequential stimulation of first the atrium and then the ventricle to cause the heart to beat in a more natural and thus efficient manner.
- the sinus node causes the atrium to contract first and then send electrical stimulus through fibers in heart walls to the ventricle causing its contraction.
- Such a pacer is one according to US. Pat. No. 3,595,242 entitled Atrial and Ventricular Demand Pacer which is capable of supplying this sequential atrium-ventricle stimulation. Background material disclosed in this patent is incorporated herein by reference.
- the present invention seeks to provide a single catheter construction which includes electrodes for separately stimulating both the atrium and the ventricle while simultaneously assuring good contact with the atrium.
- a catheter construction capable of stimulating both the atrium and the ventricle.
- the system is likewise capable of pacing either or both the atrial and the ventricles whether or not the need of such a capability was manifest at the time of initial pacer electrode implantation.
- cardiac output has been increased by as much as 24 percent according to published literature.
- This system is also applicable to a large number of patients with the variety of other arrhythmias that require cardiac pacing. Many of these patients are now of necessity paced by way of the right ventricle with unavoidable A-V dissociation.
- A-V synchronization should be expected to increase cardiac output.
- mean left atrial pressure would be anticipated to be lower in A-V pacing than in A-V dissociation given any constant left ventricular end diastolic pressure. This being true, I would anticipate mean pulmonary artery capillary pressure to be reduced, decreasing any tendency towards transudation, pulmonary edema, hypoxia, and other ventilatory and perfusion abnormalities.
- the co-axial catheter system of this invention has the advantage of using the transvenous technique of insertion (no major surgery is required), with a low associated morbidity and is stable and reliable for long term pacing.
- transvenous pacemaker cathode electrode system which can be easily placed in both the atrium and ventricle and is reliable and stable in these positions. It is a further object of the invention to provide a pacer catheter electrode system capable of implantation by the transvenous technique, which is easy to implant, and is capable of long term pacing characterized by stability and reliability in place.
- a catheter electrode system is comprised of a series of concentric elements including a substantially centrally located, reciprocally movable ventricular electrode encapsulated within a hollow catheter cover.
- Movably associated with the catheter cover is a pair of atrial leads.
- the leads are mounted from each other on the outer surface of said catheter.
- the distal end of the atrial leads are deformed. The deformation is such that an outer sheet or catheter mounted about the inner catheter compresses the deformed atrial leads into close association with the inner catheter.
- the outer sheath is pulled back allowing the deformed ends of the atrial leads to spring open and nest against (snug up against) adjacent walls of the atrium.
- FIG. I is a schematic representation of an illustrative embodiment of the present invention placed within the heart
- FIG. 2 is a schematic elevation in partial section of a catheter electrode system according to this invention.
- FIG. 3 is an end view of a system according to this invention showing the atrial leads extended as in their atrial wall-contacting configuration;
- FIG. 4 is an alternative embodiment of the invention.
- FIGS. 5 and 6 are yet another alternative embodiment.
- FIG. 1 I have shown a schematic view of a heart 10.
- the heart includes a right ventricle 11 and an associated atrium l2.
- I3 Entering through the superior vena cava I3 is a catheter construction 15 according to my invention.
- the construction includes a ventricular lead 16, a number 9 French (or other) catheter 17 concentrically positioned about the lead 16 and having secured to opposed outer surface positions thereof a pair of atrial leads 18 and 19.
- I am describing positions 180 relative to each other.
- Concentric the inner catheter 17 is an outer catheter or sheath 20. Referring, for the moment, to FIG.
- the bipolar ventricular lead 16 is shown to be comprised of a pair of electrodes 25 and 26.
- the electrodes 25 and 26 are encapsulated in suitable electrical insulating material and from the plug 16 to the opposite end are concentric to each other. At the internal end, the leads 25 and 26 are exposed for contact with a ventricle wall.
- This is a typical bipolar pacing catheter in common use. The instant embodiment would work equally as well in a unipolar requiring only electrode 26. The other pole then becomes the pulse generator itself or other remote or distant pole.
- Mounted about the concentric ventricle leads q5 and 26 is the sheath 17 which in the embodiment I am describing herein was a number 9 French catheter (or similar/equivalent).
- each of the leads l8 and 19 is mounted 180 relative to each other on the outer surface of the French catheter 17 by attaching with epoxy resin. They extend substantially parallel to each other and are parallel to the central axis of the catheter. Substantially adjacent the distal end of each lead 18 and 19 is a bend or deformation in opposite directions. Preferrably, the planes in which the respective deformed portions reside are parallel to each other and spaced apart a length equal to the outer diameter of the catheter 17.
- the deformed ends 18 and 19 are urged towards a configuration or position which is substantially parallel to the central axis of the catheter 17.
- the deformed ends 18 and 19 spring outwardly to deformed position to thereby contact or snug against the adjacent wall of the atrium.
- the atrial conducting system might make one point on the endocardial atrial surface more advantageous to pace than another one due to lower threshold to electrical stimulation.
- electrophysiologic grounds were not the only criteria to influence the choice of position for optimal atrial pacing.
- the selected position should also be as mechanically immobile as possible. This was viewed as necessary or desirable to reduce the tendency of the pacer electrode to dislodge. In addition, it would reduce the tendency for inflammatory fibrous tissue to form about the electrode because of relative movement. The formation of such fibrous tissue can cause electrical threshold to increase.
- I mention threshold herein, I refer to that minimum level of energy which is necessary to stimulate the heart muscle.
- any lost fluid volume was promptly replaced with physiological saline solution.
- the pericardium was opened by a midline incision. Each side of the pericardium was clamped to the adjacent chest wall at the level of the original incision in the chest making a loose sling of the pericardium. The myocardium was kept wet with saline.
- the external jugular vein was isolated and cannulated.
- a standard pacer and electrode were attached and set at a rate of 150 per minute, 9 to 12 volts, with the current varying for test conditions.
- the sinoatrial node was identified and destroyed by crushing and direct perfusion with 99 percent isopropyl alcohol. Destruction of the tissues surrounding the node was kept to an absolute minimum. This caused the heart rate to slow so that it could be captured with the pacer. The rate drop was from between 150 and 200 to one between and beats per minute. Due to the dogs effective atrial escape mechanism, the heart did not stop, nor, did P waves or the QRS complex. The P wave configuration, however, changed visibly.
- any point in the right atrium is as good for pacing as any other from a threshold standpoint. Pacing can even be achieved at some slight distance from the atrial tissue. While no point within the atrium seemed particularly advantageous from a threshold standpoint anatomical considerations yielded a different result. Observations demonstrated that the area directly adjacent the junction of the vena cava to the atrium is well anchored by fascia to surrounding structures of the mediastinum. Proceeding from this position outward into the atrium produced increased movement of the electrode. In contrast, in areas close to the vena cave, movement was definitely limited. Based on these observations and the threshold data, the coaxial electrode system referred to above was designed. When implanted and placed as schematically shown in FIG.
- a standard bipolar transvenous cardiac pacer electrode (one manufactured by the Cordis Corporation of Miami, Fla. and identified Cordis 370-110) was inserted in size 9 French cardiac catheter.
- two steel wire electrodes were glued with epoxy resin.
- the wires were parallel to the catheter and 180 from each other on opposite sides of the catheter surface.
- the pacing or atrial ends were bent in the form of an S (see FIG. 3). When permitted to assume their preshaped form in the atrium, these bent ends unfolded outward as shown in FIG. 1 or FIG. 3. Endocardial contact occurred when the structure was drawn adjacent the superior vena cava-atrial junction.
- this space was filled with sterile saline (Area 31 in FIG. 2. Suitable seals were provided at 32 and 33 as shown in FIG. 2 to prevent escape of the saline).
- sterile saline Area 31 in FIG. 2.
- Suitable seals were provided at 32 and 33 as shown in FIG. 2 to prevent escape of the saline.
- the two electrodes which comprised the atrial leads were so constructed that they would not snag each other when folded or urged into position substantially parallel to the central axis of the ventricular lead 16.
- lateral movement of the atrial electrode ends is always in a direction parallel to but separate from the other electrode. This not only facilitates implantation but allows removal of the electrode system if that becomes desirable at a later date.
- One atrial lead was attached to a fixed rate pacer at beats per minute, 9 to 12 volts, 0.5 millograms (in my experimental work I utilized a pacer of the Medtronic Company of Minneapolis, Minn., designated No. 5840).
- the other atrial lead was attached to the sensing pole of a paired pulse generator, (21 pacer of the Cordis Company of Miami, Fla., designated the Cordis Synchrocor) which was thus changed to an external P-wave synchronized pacemaker.
- the ventricular pacing catheter was attached to the pacing output of this unit.
- a unitary A-V pacing unit such as that disclosed and claimed in US Pat. No. 3,595,242 discussed above, the use of two pacemakers would not be required.
- the S. A. node of each dog was destroyed as noted before or the total electrical activity of the heart was stopped with carbonyl choline, 0.25 millograms given rapidly intrave nously.
- the pacers were switched on with the ventricular pacer set at 0.5 milliamps current flow, 9 to 12 volts, with a sensitivity (for the P wave) of 0.1 millivolts and a refractory period of 300 milliseconds.
- the A-V delay was set at I00 milliseconds. The A-V delay under these conditions was less than the usual physiological delay of milliseconds. This shorter setting permitted the demonstration of ventricular capture despite the presence of an intact A-V conducting system.
- the stability and relative immobility was proven in that successful pacing was accomplished without dislodgement.
- the heart rate dropped abruptly to an average of 1 10 beats per minute until the atrial pacer was switched on at a rate of 150 beats per minute.
- the ECG showed atrial capture followed by normal QRS complexes. With both atrial and ventricular units operating, the ECG clearly showed that the ventricles as well as the atrial were captured.
- this pacing catheter may be applicable to patients in cornary care units with A-V block and compromised cardiac function with low cardiac output wherein atrial stimulation would be an advantage.
- the atrial electrode could act as a sensor of the patients own T-waves providing a trigger for a synchronized ventricular pacing pulse.
- the atrial electrode wires were fastened about the catheter encapsulating the ventricular electrode.
- the atrial electrode leads can also be built or encapsulated within the wall of this catheter.
- the atrial electrode wires were round, it would be desirable that they be flat, or rectangular in cross-section, to assist in preventing tendency towards atrial perforation, to assure better surface to surface contact with the atrium and to reduce required inner catheter space.
- plastic material having inherent slippery characteristics, such as teflon would eliminate the necessity of the liquid.
- the materials used in the preferred catheter construction were simple stainless steel catheter tip occluders (Breckenbrough Curved Tip Occluder) manufactured by United States Catheter Instrument Corporation, Catalog No. 9639 (p. 19).
- the epoxy cement used was Duro Epoxe (manufactured by Woodhill Chemicals, Cleveland, Ohio 44128, stock number EXP-1).
- FIG. 4 the construction shown in which the leads 18 and 19 are flat or rectangular in cross-section and fixed along the opposite sides (180 from each other preferably) of the sheath. These leads are spatially movable or adjustable relative to leads 25' and 26' thereby allowing adjustment of distance between atrium and ventricle stimulation a most beneficial feature of my invention since all hearts are not the same size.
- the parts of FIG. 4 bear numerals similar to FIGS. 1-3 except for the addition of prime signs since similar part designations and functions exist. The same is true of FIGS. 5 and 6 except double prime designations are used.
- FIGS. 5 and 6 a further unique feature of pacer electrode construction according to my invention will become evident.
- the atrial electrode 18" 19" is ring shaped.
- FIGS. 4, 5 and 6 may be more desirable for long term implantation since critics have suggested the electrodes 18 and 19 may become quite adherent to the atrial wall and perforation might be possible.
- An elongate pacing electrode catheter system capable of pacing both the atrium and the ventricle comprising:
- an elongate flexible electrode extending the length of the catheter system for stimulating the ventricle and comprising a ventricle electrode system, said ventricle electrode system terminating in a distal tip arranged to be moved axially of the catheter system into stimulating contact with the wall of a ventricle, an elongate atrial electrode system extending the length of the catheter system and comprising an atrial electrode system, said atrial electrode system comprised of at least two energy conducting elements reciprocally movably mounted in opposed positions about a central portion of the ventricle electrode system rearward of the distal tip thereof, said elements including stimulation distal tips,
- ventricle electrode system means allowing said ventricle electrode system to be moved relative to the atrial electrode stimulating tips when said tips are in an extended position for atrial stimulation.
- said elongate flexible ventricle electrode for stimulating the ventricle is substantially along a central axis of the system
- the elongated atrial electrode system is mounted concentric to the ventricle electrode.
- the atrial electrode system is comprised of at least two electrode wires mounted in association with said catheter.
- An elongate pacing electrode catheter system in which a catheter covering is movably mounted about a major portion of the ventricle electrode system and in which the ventricle electrode system has mounted thereabout portions of the atrial electrode system terminating in resilient deformable normally S-shaped stimulating tips.
- An elongate pacing electrode catheter system capable of pacing both the atrium and the ventricle comprising:
- an elongate flexible electrode extending the length of the catheter system for stimulating the ventricle, said electrode for stimulating the ventricle including a distal tip arranged to be moved into stimulating contact with the wall of a ventricle,
- Atrial electrode system stimulating distal tip means there being means arranged to reciprocally move said atrial electrode system stimulating distal tip means from a first substantially coaxial position to an extended operative position.
Abstract
Pacer catheter for an A-V stimulator comprising a catheter assembly which may be passed through a single channel to the heart which assembly will carry both atrial and ventricular stimulation. The catheter provides at least two mutually insulated spatially adjustable electrical conductors, one for stimulating the atrium and an additional one for stimulating the ventricle.
Description
llnited States Patent [191 Bur-es 1 Feb. 11, 1975 1 TRANSVENOUS COAXIAL CATHETER [75] lnventor: Alan R. Bures, Irvine, Calif.
[7 3] Assignee: The Regents of The University of California, Berkeley, Calif.
22 Filed: Dec. 27, 1973 211 App]. No.: 428,966
[52] US. Cl 128/404, 128/419 P OTHER PUBLICATIONS Rogel et al., Journal of Thoracic & Cardiovascular Surgery," Vol. 61, No. 3, March, 1971, pgs. 466-471.
Dorstmann et a1., American Journal of Cardiology," Vol. 30, July 11, 1972, pgs. 74 & 75,
Castillo et al., Chest," Vol. 59, No. 4, April, 1971, pgs. 360-364.
Primary Examinew-William E. Kamm Attorney, Agent, or Firm-William C. Nealon; H. R. Berkenstock, Jr.
[57] ABSTRACT Pacer catheter for an A-V stimulator comprising a catheter assembly which may be passed through a single channel to the heart which assembly will carry both atrial and ventricular stimulation. The catheter provides at least two mutually insulated spatially adjustable electrical conductors, one for stimulating the atrium and an additional one for stimulating the ventricle.
7 Claims, 6 Drawing Figures 20 K31 4/32 Kl? 6 56 TRANSVENOUS COAXIAL CATHETER FIELD OF THE INVENTION This invention relates to heart stimulation devices of the catheter type normally used to inter-connect a remotely situated pacer and a source of stimulating energy with the heart of a patient.
OF THE PRIOR ART In the electro-medical field today therapeutic heart stimulating devices are well known. Some of these devices are called heart pacers and they provide stimulation to the heart when its natural stimulating system is inoperative or diseased. Artificial stimulation is controlled to cause heartbeat at a substantially normal rate.
The more conventional pacer provides stimulation only to the ventricle, bypassing the atrium. A new type of pacer, now coming into use, provides sequential stimulation of first the atrium and then the ventricle to cause the heart to beat in a more natural and thus efficient manner. When functioning naturally, the sinus node causes the atrium to contract first and then send electrical stimulus through fibers in heart walls to the ventricle causing its contraction. Such a pacer is one according to US. Pat. No. 3,595,242 entitled Atrial and Ventricular Demand Pacer which is capable of supplying this sequential atrium-ventricle stimulation. Background material disclosed in this patent is incorporated herein by reference.
In earlier research work utilizing the sequential type pacemaker, it was found necessary to use two separate catheters, one each for the atrium and the ventricle. Either or both of the catheters was subject to dislodgement. Implantation required two veins (or one very large one). It was apparently often the case that insertion of one catheter might dislodge one previously placed. Another suggested catheter procedure included use of a J-shaped electrode system which rests its tip in the right atrium appendage. This structure also apparently could be dislodged. In addition, it has been discovered that either of these systems apparently does not offer the capability of A-V pacing should A-V block develop subsequent to the S.A. nodal disease as often occurs. With current atrial pacing techniques, a second catheter has to be implanted in order to take advantage of the increased cardiac output that sequential A-V pacing provides. Thus, the present invention seeks to provide a single catheter construction which includes electrodes for separately stimulating both the atrium and the ventricle while simultaneously assuring good contact with the atrium.
SUMMARY OF THE INVENTION According to this invention, there is provided a catheter construction capable of stimulating both the atrium and the ventricle. With the proper type of pacer, the system is likewise capable of pacing either or both the atrial and the ventricles whether or not the need of such a capability was manifest at the time of initial pacer electrode implantation. I
At present, the most common reason for long term cardiac pacing is the Stokes-Adams Syndrome. In certain instances, (as in other heart block syndromes) sequential A-V pacing has proven useful. For example, by synchronizing atrial with ventricle contractions, cardiac output has been increased by as much as 24 percent according to published literature. This system is also applicable to a large number of patients with the variety of other arrhythmias that require cardiac pacing. Many of these patients are now of necessity paced by way of the right ventricle with unavoidable A-V dissociation.
For example, those patients with myocardial infarction are not good candidates for even the limited thoracotomy which certain new procedures require. Nevertheless, myocardial infarction patients with A-V block should benefit from A-V pacing in several ways. First, as noted, A-V synchronization should be expected to increase cardiac output. Second, mean left atrial pressure would be anticipated to be lower in A-V pacing than in A-V dissociation given any constant left ventricular end diastolic pressure. This being true, I would anticipate mean pulmonary artery capillary pressure to be reduced, decreasing any tendency towards transudation, pulmonary edema, hypoxia, and other ventilatory and perfusion abnormalities. The co-axial catheter system of this invention has the advantage of using the transvenous technique of insertion (no major surgery is required), with a low associated morbidity and is stable and reliable for long term pacing.
It is thus among the objects of this invention to provide a transvenous pacemaker cathode electrode system which can be easily placed in both the atrium and ventricle and is reliable and stable in these positions. It is a further object of the invention to provide a pacer catheter electrode system capable of implantation by the transvenous technique, which is easy to implant, and is capable of long term pacing characterized by stability and reliability in place.
Briefly, a catheter electrode system according to this invention is comprised of a series of concentric elements including a substantially centrally located, reciprocally movable ventricular electrode encapsulated within a hollow catheter cover. Movably associated with the catheter cover is a pair of atrial leads. Preferrably the leads are mounted from each other on the outer surface of said catheter. The distal end of the atrial leads are deformed. The deformation is such that an outer sheet or catheter mounted about the inner catheter compresses the deformed atrial leads into close association with the inner catheter. Upon insertion of the electrode system into the heart, the outer sheath is pulled back allowing the deformed ends of the atrial leads to spring open and nest against (snug up against) adjacent walls of the atrium.
Other objects, advantages and details of the present invention will become readily apparent to those skilled in the art by referring to the detailed description which follows with reference to the appended drawings.
In these drawings:
FIG. I is a schematic representation of an illustrative embodiment of the present invention placed within the heart;
FIG. 2 is a schematic elevation in partial section of a catheter electrode system according to this invention;
FIG. 3 is an end view ofa system according to this invention showing the atrial leads extended as in their atrial wall-contacting configuration;
FIG. 4 is an alternative embodiment of the invention; and
FIGS. 5 and 6 are yet another alternative embodiment.
DESCRIPTION OF THE PREFERRED EMBODIMENT OF THE INVENTION In FIG. 1, I have shown a schematic view of a heart 10. The heart includes a right ventricle 11 and an associated atrium l2. Entering through the superior vena cava I3 is a catheter construction 15 according to my invention. The construction includes a ventricular lead 16, a number 9 French (or other) catheter 17 concentrically positioned about the lead 16 and having secured to opposed outer surface positions thereof a pair of atrial leads 18 and 19. When I mention opposed positions in the preferred embodiment, I am describing positions 180 relative to each other. Concentric the inner catheter 17 is an outer catheter or sheath 20. Referring, for the moment, to FIG. 2, the bipolar ventricular lead 16 is shown to be comprised of a pair of electrodes 25 and 26. The electrodes 25 and 26 are encapsulated in suitable electrical insulating material and from the plug 16 to the opposite end are concentric to each other. At the internal end, the leads 25 and 26 are exposed for contact with a ventricle wall. This is a typical bipolar pacing catheter in common use. The instant embodiment would work equally as well in a unipolar requiring only electrode 26. The other pole then becomes the pulse generator itself or other remote or distant pole. Mounted about the concentric ventricle leads q5 and 26 is the sheath 17 which in the embodiment I am describing herein was a number 9 French catheter (or similar/equivalent).
The internal ends of the atrial leads 18 and 19 have been described as deformed. Reference to FIG. 3 presents one with a better idea of the configuration being described. Each of the leads l8 and 19, for a substantial portion of their respective lengths, is mounted 180 relative to each other on the outer surface of the French catheter 17 by attaching with epoxy resin. They extend substantially parallel to each other and are parallel to the central axis of the catheter. Substantially adjacent the distal end of each lead 18 and 19 is a bend or deformation in opposite directions. Preferrably, the planes in which the respective deformed portions reside are parallel to each other and spaced apart a length equal to the outer diameter of the catheter 17.
Thus, in operation, when the sheath 20 is moved forwardly towards the stimulating end of the atrial leads, the deformed ends 18 and 19 are urged towards a configuration or position which is substantially parallel to the central axis of the catheter 17. Upon rearward movement of the sheath or cover 20, the deformed ends 18 and 19 spring outwardly to deformed position to thereby contact or snug against the adjacent wall of the atrium.
In initially undertaking the experimental work which resulted in this invention, it was considered necessary, or at least desirable, to determine those sites in the atrium which were the best for stimulation. The ventricular site had been decided by experim ental and clinical practice to be beneath the trabeculae just medial to the right ventricular apex. The best atrial site required further evaluation. Prior knowledge suggested that the region of the SA. node would be advantageous for many reasons. For example, atrial systole would proceed in a normal direction (cephalad to caudad direction) and the specialized atrial conducting tracts might be utilized to simulate normal ventricle systole.
Also, the possibility was investigated that the atrial conducting system might make one point on the endocardial atrial surface more advantageous to pace than another one due to lower threshold to electrical stimulation. Of course, I realized that electrophysiologic grounds were not the only criteria to influence the choice of position for optimal atrial pacing. The selected position should also be as mechanically immobile as possible. This was viewed as necessary or desirable to reduce the tendency of the pacer electrode to dislodge. In addition, it would reduce the tendency for inflammatory fibrous tissue to form about the electrode because of relative movement. The formation of such fibrous tissue can cause electrical threshold to increase. When I mention threshold" herein, I refer to that minimum level of energy which is necessary to stimulate the heart muscle.
In a first series of laboratory experiments, 5 mongrel dogs, ranging from l4 to 27 kilograms were obtained. Each animal was anesthetized with sodium pentobarbital (25 to 30 millograms per killogram of body weight). The trachea was intubated and the animal placed on a positive pressure respirator at 12 to 20 breaths per minute, breathing oxygen at a pressure of 10 to 15 centimeters of water. This previously had been shown to produce acceptable pH and pCO values while maintaining oxygenation and acceptable hemodynamics. The chest was then opened by a careful midline dissection with extreme care to minimize blood loss. In each of the five successful attempts reported here, blood loss was held to less than 125 cubic centimeters for the duration of the experiment. Any lost fluid volume was promptly replaced with physiological saline solution. After the chest was opened, the pericardium was opened by a midline incision. Each side of the pericardium was clamped to the adjacent chest wall at the level of the original incision in the chest making a loose sling of the pericardium. The myocardium was kept wet with saline.
The external jugular vein was isolated and cannulated. A standard pacer and electrode were attached and set at a rate of 150 per minute, 9 to 12 volts, with the current varying for test conditions. The sinoatrial node was identified and destroyed by crushing and direct perfusion with 99 percent isopropyl alcohol. Destruction of the tissues surrounding the node was kept to an absolute minimum. This caused the heart rate to slow so that it could be captured with the pacer. The rate drop was from between 150 and 200 to one between and beats per minute. Due to the dogs effective atrial escape mechanism, the heart did not stop, nor, did P waves or the QRS complex. The P wave configuration, however, changed visibly.
Electrical thresholds to stimulation at various points in the right atrium of the five dogs was determined and reported. For each of the experimental animals, three measurements were made of the threshold for electrical stimulation. The data for all the animals was aver aged rounded off to one significant figure and summarized. On two of the dogs, initial measurements were made I and 2 centimeters above the atrium in the superior vena cava.
The above experimental work indicated that any point in the right atrium is as good for pacing as any other from a threshold standpoint. Pacing can even be achieved at some slight distance from the atrial tissue. While no point within the atrium seemed particularly advantageous from a threshold standpoint anatomical considerations yielded a different result. Observations demonstrated that the area directly adjacent the junction of the vena cava to the atrium is well anchored by fascia to surrounding structures of the mediastinum. Proceeding from this position outward into the atrium produced increased movement of the electrode. In contrast, in areas close to the vena cave, movement was definitely limited. Based on these observations and the threshold data, the coaxial electrode system referred to above was designed. When implanted and placed as schematically shown in FIG. 1, there is assurance of proper positioning of the atrial leads adjacent the area of the atrium close to the vena cava. When implanted, upon rearward tension or movement of the coaxial system, tension is applied to the catheter drawing the atrial leads against the atrium walls maintaining good electrical contact without exerting any substantial force. The stability and relative immobility of this system allowed successful pacing without dislodgement.
The best mode now known for the practice of the invention was that structure fabricated after the above tests to determine threshold and maximum atrium stimulation points had been completed and was as follows:
A standard bipolar transvenous cardiac pacer electrode (one manufactured by the Cordis Corporation of Miami, Fla. and identified Cordis 370-110) was inserted in size 9 French cardiac catheter. To the outside of the catheter, two steel wire electrodes were glued with epoxy resin. The wires were parallel to the catheter and 180 from each other on opposite sides of the catheter surface. The pacing or atrial ends were bent in the form of an S (see FIG. 3). When permitted to assume their preshaped form in the atrium, these bent ends unfolded outward as shown in FIG. 1 or FIG. 3. Endocardial contact occurred when the structure was drawn adjacent the superior vena cava-atrial junction.
-The portions of the leads l8 and 19 making contact with the endocardium were curved and the tips blunted as shown generally at 30 in FIG. 2 and 3. Over the previously described assembly, a thin outer catheter was placed. When this was advanced over the atrial electrode wires, a small compact package was formed that was placed readily in a vein and advanced centrally thereof. When the outer catheter was withdrawn or moved rearwardly, the atrial leads unfolded to position the atrial electrodes in the position described above. The central electrode was then advanced through the number 9 French catheter into the ventricle and ma nipulated into position for good electrode contact.
To prevent blood from refluxing between the inner and outer catheters or covers by capillary action, this space was filled with sterile saline (Area 31 in FIG. 2. Suitable seals were provided at 32 and 33 as shown in FIG. 2 to prevent escape of the saline). It should be noted that the two electrodes which comprised the atrial leads were so constructed that they would not snag each other when folded or urged into position substantially parallel to the central axis of the ventricular lead 16. Also, as noted above, since the atrial leads are in two different parallel planes, lateral movement of the atrial electrode ends is always in a direction parallel to but separate from the other electrode. This not only facilitates implantation but allows removal of the electrode system if that becomes desirable at a later date.
With a coaxial pacer electrode constructed as described above, 4 mongrel dogs weighing 9 to 27 kilograms were paced for short periods (from 20 minutes to 1 hour). The chest was opened as before and the right external jugular vein cannulated using the coaxial system described. When the right atrium was reached, the outer catheter was withdrawn allowing the atrial leads to unfold. The catheter to which they were attached was withdrawn until the electrodes contacted the antrial-superior vena cava border. The center ventricular lead was then advanced into the ventricle and manipulated to assure good pacing contact. One atrial lead was attached to a fixed rate pacer at beats per minute, 9 to 12 volts, 0.5 millograms (in my experimental work I utilized a pacer of the Medtronic Company of Minneapolis, Minn., designated No. 5840). The other atrial lead was attached to the sensing pole of a paired pulse generator, (21 pacer of the Cordis Company of Miami, Fla., designated the Cordis Synchrocor) which was thus changed to an external P-wave synchronized pacemaker. The ventricular pacing catheter was attached to the pacing output of this unit. Of course, utilizing a unitary A-V pacing unit such as that disclosed and claimed in US Pat. No. 3,595,242 discussed above, the use of two pacemakers would not be required.
In any event, using the arrangement described above, including two different pacemakers, the S. A. node of each dog was destroyed as noted before or the total electrical activity of the heart was stopped with carbonyl choline, 0.25 millograms given rapidly intrave nously. The pacers were switched on with the ventricular pacer set at 0.5 milliamps current flow, 9 to 12 volts, with a sensitivity (for the P wave) of 0.1 millivolts and a refractory period of 300 milliseconds. The A-V delay was set at I00 milliseconds. The A-V delay under these conditions was less than the usual physiological delay of milliseconds. This shorter setting permitted the demonstration of ventricular capture despite the presence of an intact A-V conducting system. Artificially shortening the A-V conduction time obviated the difficult problem of sectioning the His bundle to produce A-V block. Nevertheless, under the influence of carbonyl choline used in the last animal to generate total asystole, sequential atrioventricular pacing was achieved as in the other animals. In all animals on which the experiment was carried out, capture was proven by recording sequential paced beats on a surface electrocardiogram.
As mentioned, the relationship between the ventricular lead and the atrial leads as well as the tension which is applied when the catheter is drawn up against the high right atrium, maintains good electrical contact without exerting great force. The stability and relative immobility was proven in that successful pacing was accomplished without dislodgement.
With the S. A. node destroyed, the heart rate dropped abruptly to an average of 1 10 beats per minute until the atrial pacer was switched on at a rate of 150 beats per minute. The ECG showed atrial capture followed by normal QRS complexes. With both atrial and ventricular units operating, the ECG clearly showed that the ventricles as well as the atrial were captured.
With the latter four dogs, in the initial three experiments, wherein the sinus node was destroyed, identical results were obtained. Furthermore, during the time the animals were paced (at least 30 minutes each) no complications were encountered. Other than occassional permature beats at the time of placement, no arrhythmiaswere incuded. No atrial or ventricular clotting was found. The sealing system prevented blood reflux between the two catheters and the use of a standard flexible ventricular pacing catheter aided maintenance of electrical contact with the endocardium without perforation. In the fourth animal, wherein the inntravenous carbonyl choline was used to suppress all electrical activity of the heart instead of local destruction of tissue, the same results were obtained.
In addition to its potential capability for long-term pacing, my work suggest that the coaxial electrode system offers usefulness on a short term basis. For example, this pacing catheter may be applicable to patients in cornary care units with A-V block and compromised cardiac function with low cardiac output wherein atrial stimulation would be an advantage. In this circumstance, the atrial electrode could act as a sensor of the patients own T-waves providing a trigger for a synchronized ventricular pacing pulse.
In the embodiment discussed above, the atrial electrode wires were fastened about the catheter encapsulating the ventricular electrode. The atrial electrode leads can also be built or encapsulated within the wall of this catheter. In addition, while in the embodiment discussed above, the atrial electrode wires were round, it would be desirable that they be flat, or rectangular in cross-section, to assist in preventing tendency towards atrial perforation, to assure better surface to surface contact with the atrium and to reduce required inner catheter space. In the construction discussed above, I described use of saline with an oil seal. In a more refined embodiment, it is suggested the use of plastic material having inherent slippery characteristics, such as teflon, would eliminate the necessity of the liquid.
The materials used in the preferred catheter construction were simple stainless steel catheter tip occluders (Breckenbrough Curved Tip Occluder) manufactured by United States Catheter Instrument Corporation, Catalog No. 9639 (p. 19). Next, the epoxy cement used was Duro Epoxe (manufactured by Woodhill Chemicals, Cleveland, Ohio 44128, stock number EXP-1).
Alternative catheter constructions are possible using many of the inventive features herein disclosed. For example, the construction shown in FIG. 4 in which the leads 18 and 19 are flat or rectangular in cross-section and fixed along the opposite sides (180 from each other preferably) of the sheath. These leads are spatially movable or adjustable relative to leads 25' and 26' thereby allowing adjustment of distance between atrium and ventricle stimulation a most beneficial feature of my invention since all hearts are not the same size. The parts of FIG. 4 bear numerals similar to FIGS. 1-3 except for the addition of prime signs since similar part designations and functions exist. The same is true of FIGS. 5 and 6 except double prime designations are used.
Referring to FIGS. 5 and 6, a further unique feature of pacer electrode construction according to my invention will become evident. In FIGS. 5 and 6, the atrial electrode 18" 19" is ring shaped.
The arrangements of FIGS. 4, 5 and 6 may be more desirable for long term implantation since critics have suggested the electrodes 18 and 19 may become quite adherent to the atrial wall and perforation might be possible.
In the preferred construction discussed above, I have shown two atrial electrodes. It is, of course, recognized that more or less than two electrodes could be used. For example, three or more electrode leads spaced approximately equally about the ventricle electrode.
Having thus described a preferred embodiment and the best mode now known for the practice of my invention what is desired to have protected by letters patent is set forth in the following claim.
I claim: 1. An elongate pacing electrode catheter system capable of pacing both the atrium and the ventricle comprising:
an elongate flexible electrode extending the length of the catheter system for stimulating the ventricle and comprising a ventricle electrode system, said ventricle electrode system terminating in a distal tip arranged to be moved axially of the catheter system into stimulating contact with the wall of a ventricle, an elongate atrial electrode system extending the length of the catheter system and comprising an atrial electrode system, said atrial electrode system comprised of at least two energy conducting elements reciprocally movably mounted in opposed positions about a central portion of the ventricle electrode system rearward of the distal tip thereof, said elements including stimulation distal tips,
there being means arranged to reciprocally move said atrial electrode system stimulating distal tips from a collapsed to an extended operative position,
means allowing said ventricle electrode system to be moved relative to the atrial electrode stimulating tips when said tips are in an extended position for atrial stimulation.
2. The electrode system of claim 1 in which:
said elongate flexible ventricle electrode for stimulating the ventricle is substantially along a central axis of the system,
and the elongated atrial electrode system is mounted concentric to the ventricle electrode.
3. The system of claim 2 in which the means arranged to reciprocally move said atrial electrode system is a catheter through the center of which passes the ventricle electrode.
4. The system of claim 3 in which the atrial electrode system is comprised of at least two electrode wires mounted in association with said catheter.
5. The system of claim 4 in which a second catheterlike member is mounted for reciprocal movement over said electrode wires.
6. An elongate pacing electrode catheter system according to claim 1 in which a catheter covering is movably mounted about a major portion of the ventricle electrode system and in which the ventricle electrode system has mounted thereabout portions of the atrial electrode system terminating in resilient deformable normally S-shaped stimulating tips.
7. An elongate pacing electrode catheter system capable of pacing both the atrium and the ventricle comprising:
an elongate flexible electrode extending the length of the catheter system for stimulating the ventricle, said electrode for stimulating the ventricle including a distal tip arranged to be moved into stimulating contact with the wall of a ventricle,
there being means arranged to reciprocally move said atrial electrode system stimulating distal tip means from a first substantially coaxial position to an extended operative position.
Claims (7)
1. An elongate pacing electrode catheter system capable of pacing both the atrium and the ventricle comprising: an elongate flexible electrode extending the length of the catheter system for stimulating the ventricle and comprising a ventricle electrode system, said ventricle electrode system terminating in a distal tip arranged to be moved axially of the catheter system into stimulating contact with the wall of a ventricle, an elongate atrial electrode system extending the length of the catheter system and comprising an atrial electrode system, said atrial electrode system comprised of at least two energy conducting elements reciprocally movably mounted in opposed positions about a central portion of the ventricle electrode system rearward of the distal tip thereof, said elements including stimulation distal tips, there being means arranged to reciprocally move said atrial electrode system stimulating distal tips from a collapsed to an extended operative position, means allowing said ventricle electrode system to be moved relative to the atrial electrode stimulating tips when said tips are in an extended position for atrial stimulation.
2. The electrode system of claim 1 in which: said elongate flexible ventricle electrode for stimulating the ventricle is substantially along a central axis of the system, and the elongated atrial electrode system is mounted concentric to the ventricle electrode.
3. The system of claim 2 in which the means arranged to reciprocally move said atrial electrode system is a catheter through the center of which passes the ventricle electrode.
4. The system of claim 3 in which the atrial electrode system is comprised of at least two electrode wires mounted in association with said catheter.
5. The system of claim 4 in which a second catheterlike member is mounted for reciprocal movement over said electrode wires.
6. An elongate pacing electrode catheter system according to claim 1 in which a catheter covering is movably mounted about a major portion of the ventricle electrode system and in which the ventricle electrode system has mounted thereabout portions of the atrial electrode system terminating in resilient deformable normally S-shaped stimulating tips.
7. An elongate pacing electrode catheter system capable of pacing both the atrium and the ventricle comprising: an elongate flexible electrode extending the length of the catheter system for stimulating the ventricle, said electrode for stimulating the ventricle including a distal tip arranged to be moved into stimulating contact with the wall of a ventricle, an elongate atrial electrode system, said atrial electrode system comprised of at least one energy conducting element mounted about a central portion of the ventricle electrode rearward of the distal tip thereof, said elements including stimulation distal tip means, there being means arranged to reciprocally move said atrial electrode system stimulating distal tip means from a first substantially coaxial position to an extended operative position.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US428966A US3865118A (en) | 1973-12-27 | 1973-12-27 | Transvenous coaxial catheter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US428966A US3865118A (en) | 1973-12-27 | 1973-12-27 | Transvenous coaxial catheter |
Publications (1)
Publication Number | Publication Date |
---|---|
US3865118A true US3865118A (en) | 1975-02-11 |
Family
ID=23701175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US428966A Expired - Lifetime US3865118A (en) | 1973-12-27 | 1973-12-27 | Transvenous coaxial catheter |
Country Status (1)
Country | Link |
---|---|
US (1) | US3865118A (en) |
Cited By (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3949757A (en) * | 1974-05-13 | 1976-04-13 | Sabel George H | Catheter for atrio-ventricular pacemaker |
US4057067A (en) * | 1976-04-06 | 1977-11-08 | Lajos Thomas Z | Atrioventricular electrode |
US4112952A (en) * | 1977-02-11 | 1978-09-12 | The United States Of America As Represented By The Secretary Of Health, Education And Welfare | Electrode for artificial pacemaker |
US4136703A (en) * | 1978-03-09 | 1979-01-30 | Vitatron Medical B.V. | Atrial lead and method of inserting same |
FR2460683A1 (en) * | 1979-06-28 | 1981-01-30 | Medtronic Inc | ADJUSTABLE BIPOLAR TEMPORARY DRIVER, IN PARTICULAR FOR TEMPORARY STIMULATION OF THE HEART |
FR2460681A1 (en) * | 1979-06-28 | 1981-01-30 | Medtronic Inc | Transvenous connector for pacemaker - has anchoring loop and sliding inner insulated conductor making contact with wall of ventricle (NL 30.12.80) |
EP0024913A1 (en) * | 1979-08-28 | 1981-03-11 | American Pacemaker Corporation | Electrodes for cardiac pacemakers |
US4289144A (en) * | 1980-01-10 | 1981-09-15 | Medtronic, Inc. | A-V Sidearm lead |
US4289138A (en) * | 1980-06-09 | 1981-09-15 | Medical Testing Systems, Inc. | Electrode assembly for temporary pacing and heart measurements |
US4332259A (en) * | 1979-09-19 | 1982-06-01 | Mccorkle Jr Charles E | Intravenous channel cardiac electrode and lead assembly and method |
DE3143437A1 (en) * | 1980-11-03 | 1982-07-01 | Medtronic, Inc., 55440 Minneapolis, Minn. | COMBINED TWO-CHAMBER PACER LINE |
FR2510390A1 (en) * | 1981-07-31 | 1983-02-04 | Cardiofrance Co | SLIDING COAXIAL PROBE FOR CARDIAC STIMULATOR |
WO1983004181A1 (en) * | 1982-05-24 | 1983-12-08 | Mccorkle Charles E Jr | Intravenous channel cardiac electrode and lead assembly and method |
US4458677A (en) * | 1979-09-19 | 1984-07-10 | Mccorkle Jr Charles E | Intravenous channel cardiac electrode and lead assembly and method |
US4479500A (en) * | 1982-09-16 | 1984-10-30 | Medtronic, Inc. | Pacing lead with A-V distance adapter |
US4522212A (en) * | 1983-11-14 | 1985-06-11 | Mansfield Scientific, Inc. | Endocardial electrode |
USRE32204E (en) * | 1980-06-09 | 1986-07-15 | Mansfield Scientific, Inc. | Electrode assembly for temporary pacing and heart measurements |
US4602645A (en) * | 1982-12-16 | 1986-07-29 | C. R. Bard, Inc. | Atrio-ventricular pacing catheter |
US4630611A (en) * | 1981-02-02 | 1986-12-23 | Medtronic, Inc. | Orthogonally-sensing lead |
US4643201A (en) * | 1981-02-02 | 1987-02-17 | Medtronic, Inc. | Single-pass A-V lead |
US4699147A (en) * | 1985-09-25 | 1987-10-13 | Cordis Corporation | Intraventricular multielectrode cardial mapping probe and method for using same |
US4733669A (en) * | 1985-05-24 | 1988-03-29 | Cardiometrics, Inc. | Blood flow measurement catheter |
US4750494A (en) * | 1981-05-12 | 1988-06-14 | Medtronic, Inc. | Automatic implantable fibrillation preventer |
US4759378A (en) * | 1982-10-14 | 1988-07-26 | American Hospital Supply Corporation | Flexible tip cardiac pacing catheter |
US5010894A (en) * | 1988-01-07 | 1991-04-30 | Edhag Knut O | Intravascular electrode lead usable for cardiac defibrillation |
US5052407A (en) * | 1988-04-14 | 1991-10-01 | Mieczyslaw Mirowski | Cardiac defibrillation/cardioversion spiral patch electrode |
EP0479435A2 (en) * | 1990-10-01 | 1992-04-08 | Ventritex, Inc. | Multiple electrode deployable lead |
US5324321A (en) * | 1992-12-22 | 1994-06-28 | Medtronic, Inc. | Medical electrical lead having sigmoidal conductors and non-circular lumens |
US5433729A (en) * | 1991-04-12 | 1995-07-18 | Incontrol, Inc. | Atrial defibrillator, lead systems, and method |
US5551426A (en) * | 1993-07-14 | 1996-09-03 | Hummel; John D. | Intracardiac ablation and mapping catheter |
US5628778A (en) * | 1994-11-21 | 1997-05-13 | Medtronic Inc. | Single pass medical electrical lead |
US5674274A (en) * | 1995-12-14 | 1997-10-07 | Pacesetter, Inc. | Implantable adjustable single-pass A-V lead for use with an implantable stimulation device |
WO1999011320A1 (en) | 1997-09-02 | 1999-03-11 | Medtronic, Inc. | Single pass lead and method of use |
WO1999015231A1 (en) | 1997-09-25 | 1999-04-01 | Medtronic, Inc. | Single pass medical electrical lead |
US5948014A (en) * | 1998-01-23 | 1999-09-07 | Pacesetter, Inc. | Implantable stimulation system having a single-pass, tripolar lead and programmable polarity |
USH1905H (en) * | 1997-03-21 | 2000-10-03 | Medtronic, Inc. | Mechanism for adjusting the exposed surface area and position of an electrode along a lead body |
US6148238A (en) * | 1998-08-10 | 2000-11-14 | Medtronic, Inc. | Pacing leads having a brachiocephalic tine or star tine |
US6549812B1 (en) | 1999-11-29 | 2003-04-15 | Medtronic, Inc. | Medical electrical lead having bending stiffness which increase in the distal direction |
US6556873B1 (en) | 1999-11-29 | 2003-04-29 | Medtronic, Inc. | Medical electrical lead having variable bending stiffness |
US6574512B1 (en) | 2000-08-28 | 2003-06-03 | Cardiac Pacemakers, Inc. | Lead system with main lead and transverse lead |
US6711443B2 (en) * | 2001-07-25 | 2004-03-23 | Oscor Inc. | Implantable coronary sinus lead and method of implant |
US20040102830A1 (en) * | 2002-11-22 | 2004-05-27 | Williams Terrell M. | System for coupling an implanatable medical device to an epicardial site |
US20040260182A1 (en) * | 2003-06-23 | 2004-12-23 | Zuluaga Andres F. | Intraluminal spectroscope with wall contacting probe |
US20060241704A1 (en) * | 2005-04-25 | 2006-10-26 | Allan Shuros | Method and apparatus for pacing during revascularization |
US7229450B1 (en) * | 2003-02-11 | 2007-06-12 | Pacesetter, Inc. | Kink resistant introducer with mapping capabilities |
US20090318991A1 (en) * | 2008-06-19 | 2009-12-24 | Tomaschko Daniel K | Pacing catheter for access to multiple vessels |
US20090318994A1 (en) * | 2008-06-19 | 2009-12-24 | Tracee Eidenschink | Transvascular balloon catheter with pacing electrodes on shaft |
US20090318984A1 (en) * | 2008-06-19 | 2009-12-24 | Mokelke Eric A | External pacemaker with automatic cardioprotective pacing protocol |
US20090318749A1 (en) * | 2008-06-19 | 2009-12-24 | Craig Stolen | Method and apparatus for pacing and intermittent ischemia |
US20090318989A1 (en) * | 2008-06-19 | 2009-12-24 | Tomaschko Daniel K | Pacing catheter with stent electrode |
US20090318993A1 (en) * | 2008-06-19 | 2009-12-24 | Tracee Eidenschink | Pacemaker integrated with vascular intervention catheter |
US20100004706A1 (en) * | 2008-07-01 | 2010-01-07 | Mokelke Eric A | Pacing system controller integrated into indeflator |
US20100056858A1 (en) * | 2008-09-02 | 2010-03-04 | Mokelke Eric A | Pacing system for use during cardiac catheterization or surgery |
US20100228310A1 (en) * | 2009-03-09 | 2010-09-09 | Shuros Allan C | Systems and methods for autonomic nerve modulation |
US20110077701A1 (en) * | 2005-12-23 | 2011-03-31 | Sih Haris J | Method and apparatus for tissue protection against ischemia using remote conditioning |
US7957819B1 (en) * | 2005-12-19 | 2011-06-07 | Frank Avellanet | Disposable low profile transvenous electrode system for sequentially pacing the heart's right atrium and right ventricle (AV) |
US20110224606A1 (en) * | 2010-03-10 | 2011-09-15 | Shibaji Shome | Method and apparatus for remote ischemic conditioning during revascularization |
US20120178317A1 (en) * | 2011-01-07 | 2012-07-12 | Hypertronics Corporation | Electrical Contact With Embedded Wiring |
US8244352B2 (en) | 2008-06-19 | 2012-08-14 | Cardiac Pacemakers, Inc. | Pacing catheter releasing conductive liquid |
US8346339B2 (en) | 2011-04-22 | 2013-01-01 | Topera, Inc. | Basket style cardiac mapping catheter having a flexible electrode assembly for detection of cardiac rhythm disorders |
US9037235B2 (en) | 2008-06-19 | 2015-05-19 | Cardiac Pacemakers, Inc. | Pacing catheter with expandable distal end |
US9656090B2 (en) | 2002-11-15 | 2017-05-23 | Medtronic, Inc. | Human-implantable-neurostimulator user interface having multiple levels of abstraction |
US9849295B2 (en) | 2006-02-24 | 2017-12-26 | Medtronic, Inc. | User interface with 3D environment for configuring stimulation therapy |
US10279166B2 (en) | 2006-02-24 | 2019-05-07 | Medtronic, Inc. | Unwrapped 2D view of a stimulation lead with complex electrode array geometry |
US11058880B2 (en) | 2018-03-23 | 2021-07-13 | Medtronic, Inc. | VFA cardiac therapy for tachycardia |
US11213676B2 (en) | 2019-04-01 | 2022-01-04 | Medtronic, Inc. | Delivery systems for VfA cardiac therapy |
US11235161B2 (en) | 2018-09-26 | 2022-02-01 | Medtronic, Inc. | Capture in ventricle-from-atrium cardiac therapy |
US11235159B2 (en) | 2018-03-23 | 2022-02-01 | Medtronic, Inc. | VFA cardiac resynchronization therapy |
US11305127B2 (en) | 2019-08-26 | 2022-04-19 | Medtronic Inc. | VfA delivery and implant region detection |
US11400296B2 (en) | 2018-03-23 | 2022-08-02 | Medtronic, Inc. | AV synchronous VfA cardiac therapy |
US11679265B2 (en) | 2019-02-14 | 2023-06-20 | Medtronic, Inc. | Lead-in-lead systems and methods for cardiac therapy |
US11697025B2 (en) | 2019-03-29 | 2023-07-11 | Medtronic, Inc. | Cardiac conduction system capture |
US11712188B2 (en) | 2019-05-07 | 2023-08-01 | Medtronic, Inc. | Posterior left bundle branch engagement |
US11813464B2 (en) | 2020-07-31 | 2023-11-14 | Medtronic, Inc. | Cardiac conduction system evaluation |
US11813466B2 (en) | 2020-01-27 | 2023-11-14 | Medtronic, Inc. | Atrioventricular nodal stimulation |
US11911168B2 (en) | 2020-04-03 | 2024-02-27 | Medtronic, Inc. | Cardiac conduction system therapy benefit determination |
US11951313B2 (en) | 2018-11-17 | 2024-04-09 | Medtronic, Inc. | VFA delivery systems and methods |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3478746A (en) * | 1965-05-12 | 1969-11-18 | Medtronic Inc | Cardiac implantable demand pacemaker |
US3754555A (en) * | 1971-10-05 | 1973-08-28 | G Schmitt | Controllable barbed intracardial electrode |
-
1973
- 1973-12-27 US US428966A patent/US3865118A/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3478746A (en) * | 1965-05-12 | 1969-11-18 | Medtronic Inc | Cardiac implantable demand pacemaker |
US3754555A (en) * | 1971-10-05 | 1973-08-28 | G Schmitt | Controllable barbed intracardial electrode |
Cited By (126)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3949757A (en) * | 1974-05-13 | 1976-04-13 | Sabel George H | Catheter for atrio-ventricular pacemaker |
US4057067A (en) * | 1976-04-06 | 1977-11-08 | Lajos Thomas Z | Atrioventricular electrode |
US4112952A (en) * | 1977-02-11 | 1978-09-12 | The United States Of America As Represented By The Secretary Of Health, Education And Welfare | Electrode for artificial pacemaker |
US4136703A (en) * | 1978-03-09 | 1979-01-30 | Vitatron Medical B.V. | Atrial lead and method of inserting same |
US4271847A (en) * | 1979-06-28 | 1981-06-09 | Medtronic, Inc. | Temporary adjustable bipolar lead |
FR2460683A1 (en) * | 1979-06-28 | 1981-01-30 | Medtronic Inc | ADJUSTABLE BIPOLAR TEMPORARY DRIVER, IN PARTICULAR FOR TEMPORARY STIMULATION OF THE HEART |
FR2460681A1 (en) * | 1979-06-28 | 1981-01-30 | Medtronic Inc | Transvenous connector for pacemaker - has anchoring loop and sliding inner insulated conductor making contact with wall of ventricle (NL 30.12.80) |
EP0024913A1 (en) * | 1979-08-28 | 1981-03-11 | American Pacemaker Corporation | Electrodes for cardiac pacemakers |
US4386615A (en) * | 1979-08-28 | 1983-06-07 | Edgar Sowton | Electrodes for cardiac pacemakers |
US4332259A (en) * | 1979-09-19 | 1982-06-01 | Mccorkle Jr Charles E | Intravenous channel cardiac electrode and lead assembly and method |
US4458677A (en) * | 1979-09-19 | 1984-07-10 | Mccorkle Jr Charles E | Intravenous channel cardiac electrode and lead assembly and method |
US4289144A (en) * | 1980-01-10 | 1981-09-15 | Medtronic, Inc. | A-V Sidearm lead |
US4289138A (en) * | 1980-06-09 | 1981-09-15 | Medical Testing Systems, Inc. | Electrode assembly for temporary pacing and heart measurements |
FR2483786A1 (en) * | 1980-06-09 | 1981-12-11 | Medical Testing Systems Inc | ASSEMBLY OF ONE OR MORE ELECTRODES INTENDED TO BE INTRODUCED IN A CATHETER AND TO ESTABLISH AN ELECTRICAL CONNECTION WITH AN ELECTRONIC CIRCUIT |
USRE32204E (en) * | 1980-06-09 | 1986-07-15 | Mansfield Scientific, Inc. | Electrode assembly for temporary pacing and heart measurements |
DE3143437A1 (en) * | 1980-11-03 | 1982-07-01 | Medtronic, Inc., 55440 Minneapolis, Minn. | COMBINED TWO-CHAMBER PACER LINE |
US4630611A (en) * | 1981-02-02 | 1986-12-23 | Medtronic, Inc. | Orthogonally-sensing lead |
US4643201A (en) * | 1981-02-02 | 1987-02-17 | Medtronic, Inc. | Single-pass A-V lead |
US4750494A (en) * | 1981-05-12 | 1988-06-14 | Medtronic, Inc. | Automatic implantable fibrillation preventer |
EP0071495A2 (en) * | 1981-07-31 | 1983-02-09 | Cardiofrance- Compagnie Francaise D'electrocardiologie | Coaxial sliding probe for a cardiac stimulator |
EP0071495A3 (en) * | 1981-07-31 | 1984-09-05 | Cardiofrance- Compagnie Francaise D'electrocardiologie | Coaxial sliding probe for a cardiac stimulator |
FR2510390A1 (en) * | 1981-07-31 | 1983-02-04 | Cardiofrance Co | SLIDING COAXIAL PROBE FOR CARDIAC STIMULATOR |
US4574814A (en) * | 1981-07-31 | 1986-03-11 | Cardiofrance-Compagnie Francaise D'electrocardiologie | Sliding coaxial probe for a pacemaker |
WO1983004181A1 (en) * | 1982-05-24 | 1983-12-08 | Mccorkle Charles E Jr | Intravenous channel cardiac electrode and lead assembly and method |
US4479500A (en) * | 1982-09-16 | 1984-10-30 | Medtronic, Inc. | Pacing lead with A-V distance adapter |
US4759378A (en) * | 1982-10-14 | 1988-07-26 | American Hospital Supply Corporation | Flexible tip cardiac pacing catheter |
US4602645A (en) * | 1982-12-16 | 1986-07-29 | C. R. Bard, Inc. | Atrio-ventricular pacing catheter |
US4522212A (en) * | 1983-11-14 | 1985-06-11 | Mansfield Scientific, Inc. | Endocardial electrode |
US4733669A (en) * | 1985-05-24 | 1988-03-29 | Cardiometrics, Inc. | Blood flow measurement catheter |
US4699147A (en) * | 1985-09-25 | 1987-10-13 | Cordis Corporation | Intraventricular multielectrode cardial mapping probe and method for using same |
US5010894A (en) * | 1988-01-07 | 1991-04-30 | Edhag Knut O | Intravascular electrode lead usable for cardiac defibrillation |
US5052407A (en) * | 1988-04-14 | 1991-10-01 | Mieczyslaw Mirowski | Cardiac defibrillation/cardioversion spiral patch electrode |
US5282845A (en) * | 1990-10-01 | 1994-02-01 | Ventritex, Inc. | Multiple electrode deployable lead |
EP0479435A3 (en) * | 1990-10-01 | 1992-06-24 | Ventritex, Inc. | Multiple electrode deployable lead |
EP0479435A2 (en) * | 1990-10-01 | 1992-04-08 | Ventritex, Inc. | Multiple electrode deployable lead |
US5433729A (en) * | 1991-04-12 | 1995-07-18 | Incontrol, Inc. | Atrial defibrillator, lead systems, and method |
US5324321A (en) * | 1992-12-22 | 1994-06-28 | Medtronic, Inc. | Medical electrical lead having sigmoidal conductors and non-circular lumens |
US5551426A (en) * | 1993-07-14 | 1996-09-03 | Hummel; John D. | Intracardiac ablation and mapping catheter |
US5628778A (en) * | 1994-11-21 | 1997-05-13 | Medtronic Inc. | Single pass medical electrical lead |
US5995876A (en) * | 1994-11-21 | 1999-11-30 | Medtronic, Inc. | Single pass medical electrical lead |
US6006139A (en) * | 1994-11-21 | 1999-12-21 | Medtronic, Inc. | Single pass medical electrical lead with cap electrodes |
US5674274A (en) * | 1995-12-14 | 1997-10-07 | Pacesetter, Inc. | Implantable adjustable single-pass A-V lead for use with an implantable stimulation device |
USH1905H (en) * | 1997-03-21 | 2000-10-03 | Medtronic, Inc. | Mechanism for adjusting the exposed surface area and position of an electrode along a lead body |
WO1999011320A1 (en) | 1997-09-02 | 1999-03-11 | Medtronic, Inc. | Single pass lead and method of use |
US5922014A (en) * | 1997-09-02 | 1999-07-13 | Medtronic, Inc. | Single pass lead and method of use |
US6021354A (en) * | 1997-09-02 | 2000-02-01 | Medtronic, Inc. | Single pass lead and method of use |
US6201994B1 (en) | 1997-09-02 | 2001-03-13 | Medtronic, Inc. | Single pass lead and method of use |
WO1999015231A1 (en) | 1997-09-25 | 1999-04-01 | Medtronic, Inc. | Single pass medical electrical lead |
US5948014A (en) * | 1998-01-23 | 1999-09-07 | Pacesetter, Inc. | Implantable stimulation system having a single-pass, tripolar lead and programmable polarity |
US6148238A (en) * | 1998-08-10 | 2000-11-14 | Medtronic, Inc. | Pacing leads having a brachiocephalic tine or star tine |
US6718211B2 (en) | 1999-11-29 | 2004-04-06 | Medtronic, Inc. | Medical electrical lead having bending stiffnesses which increase in the distal direction |
US6549812B1 (en) | 1999-11-29 | 2003-04-15 | Medtronic, Inc. | Medical electrical lead having bending stiffness which increase in the distal direction |
US6741893B2 (en) | 1999-11-29 | 2004-05-25 | Medtronic, Inc. | Medical electrical lead having variable bending stiffness |
US6556873B1 (en) | 1999-11-29 | 2003-04-29 | Medtronic, Inc. | Medical electrical lead having variable bending stiffness |
US6871101B2 (en) | 2000-08-28 | 2005-03-22 | Cardiac Pacemakers, Inc. | Lead system with sleeve for passing a lead |
US6574512B1 (en) | 2000-08-28 | 2003-06-03 | Cardiac Pacemakers, Inc. | Lead system with main lead and transverse lead |
US6711443B2 (en) * | 2001-07-25 | 2004-03-23 | Oscor Inc. | Implantable coronary sinus lead and method of implant |
US9656090B2 (en) | 2002-11-15 | 2017-05-23 | Medtronic, Inc. | Human-implantable-neurostimulator user interface having multiple levels of abstraction |
US10441801B2 (en) | 2002-11-15 | 2019-10-15 | Medtronic, Inc. | Human-implantable-neurostimulator user interface having multiple levels of abstraction |
US20040102830A1 (en) * | 2002-11-22 | 2004-05-27 | Williams Terrell M. | System for coupling an implanatable medical device to an epicardial site |
US7229450B1 (en) * | 2003-02-11 | 2007-06-12 | Pacesetter, Inc. | Kink resistant introducer with mapping capabilities |
US20040260182A1 (en) * | 2003-06-23 | 2004-12-23 | Zuluaga Andres F. | Intraluminal spectroscope with wall contacting probe |
US20050107706A1 (en) * | 2003-06-23 | 2005-05-19 | Andres Zuluaga | Intraluminal spectroscope with wall-contacting probe |
US20100022891A1 (en) * | 2003-06-23 | 2010-01-28 | Infraredx, Inc. | Intraluminal spectroscope with wall contacting probe |
US8452400B2 (en) | 2005-04-25 | 2013-05-28 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US10549101B2 (en) | 2005-04-25 | 2020-02-04 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US9415225B2 (en) | 2005-04-25 | 2016-08-16 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US9649495B2 (en) | 2005-04-25 | 2017-05-16 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US20060241704A1 (en) * | 2005-04-25 | 2006-10-26 | Allan Shuros | Method and apparatus for pacing during revascularization |
US20110230928A1 (en) * | 2005-04-25 | 2011-09-22 | Allan Shuros | Method and apparatus for pacing during revascularization |
US7957819B1 (en) * | 2005-12-19 | 2011-06-07 | Frank Avellanet | Disposable low profile transvenous electrode system for sequentially pacing the heart's right atrium and right ventricle (AV) |
US8874207B2 (en) | 2005-12-23 | 2014-10-28 | Cardiac Pacemakers, Inc. | Method and apparatus for tissue protection against ischemia using remote conditioning |
US20110077701A1 (en) * | 2005-12-23 | 2011-03-31 | Sih Haris J | Method and apparatus for tissue protection against ischemia using remote conditioning |
US11701513B2 (en) | 2006-02-24 | 2023-07-18 | Medtronic, Inc. | Unwrapped 2D view of a stimulation lead with complex electrode array geometry |
US10286216B2 (en) | 2006-02-24 | 2019-05-14 | Medtronic, Inc. | User interface with 3D environment for configuring stimulation therapy |
US10335588B2 (en) | 2006-02-24 | 2019-07-02 | Medtronic, Inc. | Unwrapped 2D view of a stimulation lead with complex electrode array geometry |
US10279166B2 (en) | 2006-02-24 | 2019-05-07 | Medtronic, Inc. | Unwrapped 2D view of a stimulation lead with complex electrode array geometry |
US9849295B2 (en) | 2006-02-24 | 2017-12-26 | Medtronic, Inc. | User interface with 3D environment for configuring stimulation therapy |
US10342970B2 (en) | 2006-02-24 | 2019-07-09 | Medtronic, Inc. | Unwrapped 2D view of a stimulation lead with complex electrode array geometry |
US10661074B2 (en) | 2006-02-24 | 2020-05-26 | Medtronic, Inc. | Unwrapped 2D view of a stimulation lead with complex electrode array geometry |
US11090494B2 (en) | 2006-02-24 | 2021-08-17 | Medtronic, Inc. | User interface with 3D environment for configuring stimulation therapy |
US10556103B2 (en) | 2006-02-24 | 2020-02-11 | Medtronic, Inc. | Unwrapped 2D view of a stimulation lead with complex electrode array geometry |
US20090318991A1 (en) * | 2008-06-19 | 2009-12-24 | Tomaschko Daniel K | Pacing catheter for access to multiple vessels |
US8457738B2 (en) | 2008-06-19 | 2013-06-04 | Cardiac Pacemakers, Inc. | Pacing catheter for access to multiple vessels |
US20090318994A1 (en) * | 2008-06-19 | 2009-12-24 | Tracee Eidenschink | Transvascular balloon catheter with pacing electrodes on shaft |
US8639357B2 (en) | 2008-06-19 | 2014-01-28 | Cardiac Pacemakers, Inc. | Pacing catheter with stent electrode |
US8244352B2 (en) | 2008-06-19 | 2012-08-14 | Cardiac Pacemakers, Inc. | Pacing catheter releasing conductive liquid |
US20090318984A1 (en) * | 2008-06-19 | 2009-12-24 | Mokelke Eric A | External pacemaker with automatic cardioprotective pacing protocol |
US20090318749A1 (en) * | 2008-06-19 | 2009-12-24 | Craig Stolen | Method and apparatus for pacing and intermittent ischemia |
US20090318989A1 (en) * | 2008-06-19 | 2009-12-24 | Tomaschko Daniel K | Pacing catheter with stent electrode |
US9037235B2 (en) | 2008-06-19 | 2015-05-19 | Cardiac Pacemakers, Inc. | Pacing catheter with expandable distal end |
US9409012B2 (en) | 2008-06-19 | 2016-08-09 | Cardiac Pacemakers, Inc. | Pacemaker integrated with vascular intervention catheter |
US20090318993A1 (en) * | 2008-06-19 | 2009-12-24 | Tracee Eidenschink | Pacemaker integrated with vascular intervention catheter |
US8170661B2 (en) | 2008-07-01 | 2012-05-01 | Cardiac Pacemakers, Inc. | Pacing system controller integrated into indeflator |
US20100004706A1 (en) * | 2008-07-01 | 2010-01-07 | Mokelke Eric A | Pacing system controller integrated into indeflator |
US20100056858A1 (en) * | 2008-09-02 | 2010-03-04 | Mokelke Eric A | Pacing system for use during cardiac catheterization or surgery |
US20100228310A1 (en) * | 2009-03-09 | 2010-09-09 | Shuros Allan C | Systems and methods for autonomic nerve modulation |
US20110224606A1 (en) * | 2010-03-10 | 2011-09-15 | Shibaji Shome | Method and apparatus for remote ischemic conditioning during revascularization |
US8636551B2 (en) * | 2011-01-07 | 2014-01-28 | Hypertronics Corporation | Electrical contact with embedded wiring |
US20120178317A1 (en) * | 2011-01-07 | 2012-07-12 | Hypertronics Corporation | Electrical Contact With Embedded Wiring |
US8364234B2 (en) | 2011-04-22 | 2013-01-29 | Topera, Inc. | Basket style cardiac mapping catheter having spline bends for detection of cardiac rhythm disorders |
US10244960B2 (en) | 2011-04-22 | 2019-04-02 | Topera, Inc. | Basket style cardiac mapping catheter having spline bends for detection of cardiac rhythm disorders |
US9895072B2 (en) | 2011-04-22 | 2018-02-20 | Topera, Inc. | Basket style cardiac mapping catheter having an atraumatic, metallic two-part distal tip for detection of cardiac rhythm disorders |
US8346339B2 (en) | 2011-04-22 | 2013-01-01 | Topera, Inc. | Basket style cardiac mapping catheter having a flexible electrode assembly for detection of cardiac rhythm disorders |
US9560982B2 (en) | 2011-04-22 | 2017-02-07 | Topera, Inc. | Methods for detection of cardiac rhythm disorders using basket style cardiac mapping catheter |
US9504399B2 (en) | 2011-04-22 | 2016-11-29 | Topera, Inc. | Basket style cardiac mapping catheter having a flexible electrode assembly for sensing monophasic action potentials |
US8364235B2 (en) | 2011-04-22 | 2013-01-29 | Topera, Inc. | Basket style cardiac mapping catheter having an atraumatic basket tip for detection of cardiac rhythm disorders |
US8364236B2 (en) | 2011-04-22 | 2013-01-29 | Topera, Inc. | Flexible electrode assembly for insertion into body lumen or organ |
US8812074B2 (en) | 2011-04-22 | 2014-08-19 | Topera, Inc. | Methods for detection of cardiac rhythm disorders using basket style cardiac mapping catheter |
US8504133B2 (en) | 2011-04-22 | 2013-08-06 | Topera, Inc. | Basket style cardiac mapping catheter having a flexible electrode assembly and an atraumatic tip for detection of cardiac rhythm disorders |
US8644902B2 (en) | 2011-04-22 | 2014-02-04 | Topera, Inc. | Methods for detection of cardiac rhythm disorders using basket style cardiac mapping catheter |
US11235159B2 (en) | 2018-03-23 | 2022-02-01 | Medtronic, Inc. | VFA cardiac resynchronization therapy |
US11058880B2 (en) | 2018-03-23 | 2021-07-13 | Medtronic, Inc. | VFA cardiac therapy for tachycardia |
US11819699B2 (en) | 2018-03-23 | 2023-11-21 | Medtronic, Inc. | VfA cardiac resynchronization therapy |
US11400296B2 (en) | 2018-03-23 | 2022-08-02 | Medtronic, Inc. | AV synchronous VfA cardiac therapy |
US11235161B2 (en) | 2018-09-26 | 2022-02-01 | Medtronic, Inc. | Capture in ventricle-from-atrium cardiac therapy |
US11951313B2 (en) | 2018-11-17 | 2024-04-09 | Medtronic, Inc. | VFA delivery systems and methods |
US11679265B2 (en) | 2019-02-14 | 2023-06-20 | Medtronic, Inc. | Lead-in-lead systems and methods for cardiac therapy |
US11697025B2 (en) | 2019-03-29 | 2023-07-11 | Medtronic, Inc. | Cardiac conduction system capture |
US11213676B2 (en) | 2019-04-01 | 2022-01-04 | Medtronic, Inc. | Delivery systems for VfA cardiac therapy |
US11712188B2 (en) | 2019-05-07 | 2023-08-01 | Medtronic, Inc. | Posterior left bundle branch engagement |
US11305127B2 (en) | 2019-08-26 | 2022-04-19 | Medtronic Inc. | VfA delivery and implant region detection |
US11813466B2 (en) | 2020-01-27 | 2023-11-14 | Medtronic, Inc. | Atrioventricular nodal stimulation |
US11911168B2 (en) | 2020-04-03 | 2024-02-27 | Medtronic, Inc. | Cardiac conduction system therapy benefit determination |
US11813464B2 (en) | 2020-07-31 | 2023-11-14 | Medtronic, Inc. | Cardiac conduction system evaluation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3865118A (en) | Transvenous coaxial catheter | |
US7321798B2 (en) | Trans-septal/trans-myocardial ventricular pacing lead | |
US5174289A (en) | Pacing systems and methods for control of the ventricular activation sequence | |
US5267560A (en) | Methods for control of the ventricular activation sequence | |
US4913164A (en) | Extensible passive fixation mechanism for lead assembly of an implantable cardiac stimulator | |
US4858623A (en) | Active fixation mechanism for lead assembly of an implantable cardiac stimulator | |
EP1363697B1 (en) | Coronary veins lead for pacing or sensing | |
JP5588340B2 (en) | Method, apparatus and system for management of cardiac rhythm using electrode configuration | |
US20060136001A1 (en) | Ventricular pacing | |
US20030023275A1 (en) | Inter-atrial septum or superior vena cava electrodes for atrial defibrillation | |
JP6542981B2 (en) | Single pass coronary vein lead for detection and pacing in multiple chambers | |
US11660457B2 (en) | Leadless cardiac pacemaker device configured to provide his bundle pacing | |
WO2003092799A1 (en) | Pacing lead with partially masked active fixation electrode | |
CZ20012555A3 (en) | Anti-tachycardiac stimulation | |
EP3773886B1 (en) | Bundle of his lead delivery catheter and system | |
GOLDREYER et al. | A new orthogonal lead for P synchronous pacing | |
US20100137927A1 (en) | Multifunctional cardiac pacemaker system | |
Jensen et al. | Intracavitary cardiac pacing | |
Spurrell et al. | Pacing techniques in the management of supraventricular tachycardias: Part 2 an implanted atrial synchronous pacemaker with a short atrioventricular delay for the prevention of paroxysmal supraventricular tachycardias | |
US11577075B1 (en) | Transcoronary sinus pacing of his bundle | |
JPH02307481A (en) | Positive fixing mechanism for lead assembly of buried cardiotonic device | |
JP2023504565A (en) | Implantable Intravascular Small Form Factor Intracardiac Left Atrial Constraint Device for Low Energy Atrial Cardioversion, Pacing and Sensing | |
US11219772B2 (en) | Devices and Methods for cardiac pacing and resynchrontzation | |
CN106178262B (en) | A kind of wireless auricular pacemaking device being implanted into through conduit | |
Wood et al. | Temporary cardiac pacing |